BD - Earth day 2024

IceCure Medical Receives Approval from Health Canada for ProSense Cryoablation System

Tuesday, July 25, 2023

IceCure Medical has received approval from Health Canada for its minimally invasive ProSense Cryoablation System. The ProSense Cryoablation System is designed for various medical applications.

This approval allows for the use of the ProSense Cryoablation System in Canada for the following applications:

  • Ablation of benign and malignant tumours of the lung, liver, kidneys, and musculoskeletal system.
  • Ablation of benign tumours of the breast.
  • General surgery procedures.
  • Palliative interventions to alleviate symptoms and improve the quality of life for patients.
  • Other surgeries that may benefit from the cryosurgical technique.

The approval in Canada adds to the regulatory clearances IceCure Medical has already obtained in 15 countries, including the United States, Europe, and China. This expanded access in North America, along with the ongoing efforts in the U.S., can potentially create synergies and further opportunities for IceCure in the region.

This approval granted from Health Canada for the ProSense Cryoablation System will directly engage with healthcare providers in Canada allowing to introduce this innovative cryoablation system to medical professionals across the country.